Org 25969

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Org 25969, covering 2017-06-16 to 2019-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931) [Phase 3]